The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancerMengmeng Song, Hanping Shi, Hongxia Xu et al.|Journal of Cachexia Sarcopenia and Muscle|2022Cited by 170
Inflammatory burden as a prognostic biomarker for cancerHailun Xie, Hanping Shi, Guo‐Tian Ruan et al.|Clinical Nutrition|2022Cited by 152
Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancerHeyang Zhang, Hanping Shi, Jinyu Shi et al.|Nutrition|2023Cited by 75
Improving the assessment of malnutrition in cancer: Using systemic inflammation markers as a supplement to the inflammation items of the GLIM criteriaHailun Xie, Hanping Shi, Kaitao Yuan et al.|Clinical Nutrition|2023Cited by 25
AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancerHailun Xie, Hanping Shi, Lishuang Wei et al.|Journal of Cachexia Sarcopenia and Muscle|2024Cited by 18